QT Dispersion in Hypertensive Diabetic and Non-diabetic Patients with Congestive Heart Failure;Disperzia QT intervalov u hypertonických diabetikov a u pacientov s hypertenziou bez diabetu s chronickým srdcovým zlyhaním

Vnitrni Lekarstvi

Volumn 49, Issue 10, 2003, Pages 802-807

  Radman, Abdulsalam ^a   Murin J ^a   Bulas, J ^a   Reptova A ^a   Ravingerova T ^b   Mikes P ^a   Kozlikova K ^c   Ghanem, W ^a   Jaber, J ^a   Baqi, L ^a  

^a I Interna Klinika   (Slovakia)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

^c Bratislava   (Slovakia)

Author keywords

Ambulatory monitoring blood pressure; Congestive heart failure; Diabetes mellitus; QT dispersion

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART ARRHYTHMIA; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; QRS COMPLEX; QT INTERVAL; RISK ASSESSMENT; SMOKING; SYSTOLIC BLOOD PRESSURE;

DIABETES MELLITUS, TYPE 2; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED;

EID: 10744221085     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Barr, C. S., Naas, A. A., Fenwick, M., et al.: Enalapril reduces QT dispersion in patients with mild congestive heart failure secondary to coronary artery disease. Am. J. Cardiol., 79, 1997; 328-333
2. Bazett, H.: An analysis of time-relation of electrocardiograms. Heart, 7, 1920; 353-370
3. Bigger, J. T. Jr.: Why patients with congestive heart failure die: arrhythmias and sudden cardiac death. Circulation, 75, 1987; 28-35
4. Bonnar, C. E., MacFadyen, R. J., Robson, J. M. et al.: QT dispersion is related to autonomic tone in patients with chronic stable heart failure. Eur. Heart J., 18, 1997; 2000-2004
5. Buja, G., Miorelli, M., Turrini, P. et al.: Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden cardiac death. Am. J. Cardiol., 72, 1993; 973-976
6. Clarkson, P. B. M., Naas, A. A. O., McMahon, A. et al.: QT dispersion in essential hypertension. Q. J. Med., 88, 1995; 327-332
7. Cowan, J. C., Yusoff, K., Moore, M. et al.: Importance of lead selection in QT interval measurement. Am. J. Cardiol., 61, 1998; 83-87
8. Day, Ch. P., McComb, J. M., Campbell, R. W. F.: QT dispersion: an indication of arrhythmia risk in patients with long QT intervals. Brit. Heart J., 63, 1990; 342-344
9. Galinier, M., Balanescu, S., Fourcade, J. et al.: Prognostic value of arrhythmogenic markers in systemic hypertension. Eur. Heart J., 18, 1997; 1484-1491
10. Ghanem, W., Murin, J., Jaber, J.: Disperzia QT intervalov u hypertonikov s hypertrofiou l'avej komory. Vnitř Lék., 47, 2001; 20-24
11. Glancy, J. M., Garratt, C. J., Woods, K. L. et al.: QT dispersion and mortality after myocardial infarction. Lancet 1995; 345: 945-948
12. Grassi, G., Cattaneo, B. M., Mancia, G.: Sympathetic nervous system. In: Poole-Wilson, P. A., editor: Heart failure, New York: Churchill Livingstone, 1997, 199-214
13. Grimm, W., Steder, U., Menz, V. et al.: Clinical significance of increased QT dispersion in the 12-lead standard ECG for arrhythmia risk prediction in dilated cardiomyopathy. PACE, 19, 1996; 1886-889
14. Gryglewska, B., Grodzicki, T., Czarnecka, D. et al.: QT dispersion and hypertensive heart disease in the elderly. J. Hypertens., 18, 2000; 461-464
15. Kannel, W. B., McGee, D. L.: Diabetes and cardiovascular disease. The Framingham study. J. Am. Med. Assoc., 214, 1979; 2035-2038
16. Kautzner, J., Malik, M.: QT interval dispersion and its clinical utility. PACE 1997; 20: 2625-2640
17. Kimura, S., Bassett, A. L., Cameron, J. S., et al.: Cellular electrophysiological changes during ischemia in isolated coronary-perfused cat ventricle with healed myocardial infarction. Circulation, 78, 1988; 401-406
18. Kohno, I., Takusagawa, M., Yin, D. et al.: QT dispersion in dipper and nondipper type hypertension. Am. J. Hypertens, 11, 1998; 280-285
19. Konečná, P., Dvořák, R., Semrád, B.: Přínos hodnocení disperze QT intervalu v antiarytmické terapii. Vnitř. Lék., 45, 1999; 453-456
20. Kučinský, R., Gonsorčik, J., Franko, J. et al.: Súčasné možnosti klinického využitia a metodológia analýzy parametrov intervalov Q-T a jeho disperzie. Cardiol., 9, 2000; 3: 139-146
21. Kuo, C. S., Munakata, K., Reddy, C. P. et al.: Characteristics and possible mechanisms of ventricular arrhythmia dependent on the dispersion of action potential duration. Circulation, 67, 1983; 1356-1367
22. O'Brien, E., Mee, F., Atkins, N. et al.: Accuracy of the SpaceLabs 90207 determined by the British Hypertension Society protocol. J. Hypertens., 1991; 573-574
23. Parameshwar, J., Shackell, M. M., Richardson, A. et al.: Prevalence of heart failure in three general practices in north west London. Brit. J. Gen. Pract., 42, 1992; 287-289
24. Parmley, W. W., Chatterjee, K.: Congestive heart failure and arrhythmias: an overview. Am. J. Cardiol., 57, 1986; 34B-37B
25. Poulsen, P. L., Ebbehoj, E., Arildsen, H. et al.: Increased QTc dispersion is related to blunted circadian blood pressure variation in normoalbuminuric type 1. Diabetes mellitus. Diabetes, 50, 2001; 837-842
26. Radman, A., Reptová, A., Payer, J. et al.: Chronické srdcové zlyhávanie u diabetikov. Diabetes a Obezita, 2, 2002; 3: 9-20
27. Rautaharju, P. M.: Why did QT dispersion die? CEPR 2002; 6: 295-301
28. thedition), 491
29. Spargias, K. S., Lindsay, S. J., Hall, A. S. et al.: Ramipril reduces QT dispersion in patients with acute myocardial infarction and heart failure. Am. J. Cardiol., 83, 1999; 969-971
30. Spišák, V., Šrobová, A.: Disperzia QT intervalov pri akútnom infarkte myokardu so závažný mi komorovými arytmiami. Slovenský Lekár, 4, 1998; 15-17
31. The expert committee on the diagnosis and classification of diabetes mellitus: Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care, 20, 1997; 1183-1197
32. Yee, K. M., Struthers, A. D.: Can drug effects on mortality in heart failure be predicted by any surrogate marker? Eur. Heart J., 18, 1997; 1860-1864
33. Yildirir, A., Sade, E., Tokgozoglu, L. et al.: The effects of chronic carvedilol therapy on QT dispersion in patients with congestive heart failure. Eur. J. Hear Failure., 3, 2001; 717-721
34. Zabel, M., Klingenheben, T., Franz, M. R. et al.: Assessment of QT dispersion for prediction of mortality or arrhythmic events after myocardial infarction. Circulation 1998; 97: 2543-2550